Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| type II pneumocyte | 11 studies | 82% ± 20% | |
| type I pneumocyte | 7 studies | 33% ± 23% | |
| club cell | 5 studies | 33% ± 17% | |
| T cell | 3 studies | 46% ± 34% | |
| ciliated cell | 3 studies | 24% ± 9% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 7 studies | 27% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 95% | 988.86 | 233 / 245 | 82% | 135.05 | 413 / 502 |
| lung | 100% | 269780.18 | 577 / 578 | 73% | 2426.74 | 846 / 1155 |
| brain | 84% | 113.86 | 2228 / 2642 | 0% | 0 | 0 / 705 |
| pancreas | 79% | 64.27 | 259 / 328 | 2% | 0.46 | 4 / 178 |
| thymus | 60% | 72.09 | 394 / 653 | 8% | 18.13 | 49 / 605 |
| intestine | 60% | 66.64 | 581 / 966 | 3% | 1.27 | 18 / 527 |
| bladder | 43% | 30.24 | 9 / 21 | 9% | 238.93 | 46 / 504 |
| uterus | 51% | 25.71 | 86 / 170 | 1% | 0.47 | 5 / 459 |
| ovary | 51% | 380.57 | 91 / 180 | 0% | 0.04 | 1 / 430 |
| stomach | 48% | 30.78 | 171 / 359 | 2% | 0.59 | 7 / 286 |
| esophagus | 47% | 32.23 | 685 / 1445 | 2% | 10.04 | 4 / 183 |
| heart | 47% | 59.48 | 408 / 861 | 0% | 0 | 0 / 0 |
| breast | 43% | 34.68 | 197 / 459 | 3% | 0.78 | 31 / 1118 |
| adrenal gland | 43% | 45.31 | 111 / 258 | 0% | 0 | 0 / 230 |
| blood vessel | 42% | 65.58 | 565 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 42% | 47.91 | 503 / 1204 | 0% | 0 | 0 / 0 |
| kidney | 42% | 25.16 | 37 / 89 | 0% | 0.02 | 1 / 901 |
| muscle | 41% | 46.65 | 333 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 40% | 82.80 | 367 / 929 | 0% | 0 | 0 / 0 |
| liver | 39% | 47.83 | 88 / 226 | 0% | 0 | 0 / 406 |
| spleen | 37% | 21.07 | 88 / 241 | 0% | 0 | 0 / 0 |
| skin | 34% | 59.20 | 616 / 1809 | 2% | 12.89 | 9 / 472 |
| tonsil | 0% | 0 | 0 / 0 | 4% | 2.78 | 2 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007585 | Biological process | respiratory gaseous exchange by respiratory system |
| GO_0045334 | Cellular component | clathrin-coated endocytic vesicle |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005581 | Cellular component | collagen trimer |
| GO_0005576 | Cellular component | extracellular region |
| GO_0042599 | Cellular component | lamellar body |
| GO_0005771 | Cellular component | multivesicular body |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0030246 | Molecular function | carbohydrate binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SFTPA2 |
| Protein name | Pulmonary surfactant-associated protein A2 (PSP-A) (PSPA) (SP-A) (SP-A2) (35 kDa pulmonary surfactant-associated protein) (Alveolar proteinosis protein) (Collectin-5) Surfactant protein A2 variant ABD 1A (Surfactant protein A2 variant ABD' 1A) Surfactant protein A2 |
| Synonyms | SFTP1 COLEC5 SFTPA2B SFTPA PSAP |
| Description | FUNCTION: In presence of calcium ions, it binds to surfactant phospholipids and contributes to lower the surface tension at the air-liquid interface in the alveoli of the mammalian lung and is essential for normal respiration. |
| Accessions | Q8IWL1 ENST00000640627.1 ENST00000492049.1 ENST00000417041.1 A0A1W2PR89 ENST00000372325.7 R4GMN3 X6REF7 ENST00000372327.9 E3VLD0 |
